Undergoing a standard of care biopsy or excision procedure for a pigmented lesion that is suspected of being a melanoma
Willing and able to sign informed consent
Willing to undergo a non-invasive skin tape sample collection procedure prior to standard of care biopsy/excision (up to 1 week prior to or on the day of the biopsy/excision procedure)
Able to complete both the tape collection and biopsy/excision procedures
You may not be if
Individuals with significant skin disease that is outside the scope of the diseases which will be investigated
Individuals who have other skin complications at the lesion site Suspicious pigmented lesion is located on the palms, soles of feet, or a highly hair-dense anatomical site (e.g., scalp, beard area)
Individuals with learning difficulties, severely ill patients, and other vulnerable groups (e.g., mental illness, dementia)
Individuals outside the defined age group
Use of any investigational or non-registered product (drug, vaccine or invasive medical device) within the previous 8 weeks.
Individuals with an allergy that may interfere with the procedure.
Clareo Health | Development and Multi-Centre Validation of a Novel Non-Invasive Melanoma Molecular Diagnostic Test
